Resolution of Type 2 Diabetes Mellitus: Intensive vs. Conventional Glycaemic Control After Obesity Surgery (GLUCOSURG1)
Type 2 Diabetes Mellitus, Obesity
About this trial
This is an interventional treatment trial for Type 2 Diabetes Mellitus focused on measuring Type 2 Diabetes Mellitus, Obesity, Bariatric Surgery, Glycaemic control, Microvascular complications, Intensive, Conservative
Eligibility Criteria
Inclusion Criteria:
- Patients with Type 2 Diabetes Mellitus who have been approved for obesity surgery
Exclusion Criteria:
- Patients with Type 2 Diabetes Mellitus who do not require insulin immediately after obesity surgery
Sites / Locations
- Imperial College Healthcare NHS Trust
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intensive glycaemic control
Conservative glycaemic control
Intensive glycaemic control All patients will be prescribed insulin glargine once a day. The dose of the insulin will be adjusted to achieve fasting capillary glucose levels between 5-7 in the intensive group and 7-9 mmol/l in the control group.
Conservative glycaemic control All patients will be prescribed insulin glargine once a day. The dose of the insulin will be adjusted to achieve fasting capillary glucose levels between 5-7 in the intensive group and 7-9 mmol/l in the control group.